Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Galal AbouElnagah

Galal AbouElnagah

University of Alexandria, Egypt

Title: Pathological behaviors of breast cancer which could alternate surgical decisions

Biography

Biography: Galal AbouElnagah

Abstract

Surgical pathologists have a definitive role in cancer patient prognosis. The task of surgical pathologist is to provide accurate, specific, and sufficiently comprehensive information about the tumour behavior so the clinician can develop an optimal plan of treatment and estimate prognosis. The simple designation “benign” or “malignant” is not enough today. Breast cancer is not a single disease. There are distinct varieties of tumors, each with a characteristic biology. Details of breast cancer pathological behavior as the type, its differentiation, level of invasion, the number of lymph nodes with and without metastatic tumor, the presence or absence of hormone receptors, the activity of specific enzymes, ploidy, frequency of mitosis, and percentage of cells in the S-phase may all be relevant in the pathologic assessment of neoplasia. Intraoperative examination by frozen tissue sections could not usually give enough information; pathologists rely on better preservation of structure afforded by permanent tissue sections stained with hematoxylin and eosin (H & E) and occasionally other dyes. These raise the importance of preoperative diagnosis using core tissue biopsy rather than FNAC. In this presentation, the evaluation, prognostic factors, and treatment options for different pathologically different breast cancers will be discussed. Methods of surgical & oncological treatments of locally advanced cancer breast will be also discussed according to biology and clinical behavior.